Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:56 UTC |
---|
HMDB ID | HMDB0015314 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Naloxone |
---|
Description | Naloxone is only found in individuals that have used or taken this drug. It is a specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. [PubChem]While the mechanism of action of naloxone is not fully understood, the preponderance of evidence suggests that naloxone antagonizes the opioid effects by competing for the same receptor sites, especially the opioid mu receptor. Recently, naloxone has been shown to bind all three opioid receptors (mu, kappa and gamma) but the strongest binding is to the mu receptor. |
---|
Structure | [H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1(O)CCC2=O InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(-)-Naloxone | ChEBI | 1-N-Allyl-14-hydroxynordihydromorphinone | ChEBI | 17-Allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one | ChEBI | Naloxona | ChEBI | Naloxonum | ChEBI | DBL Naloxone | Kegg | 17-Allyl-3,14-dihydroxy-4,5a-epoxymorphinan-6-one | Generator | 17-Allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-one | Generator | EN 1530 base | HMDB | L-Naloxone | HMDB | N-Allylnoroxymorphone | HMDB | Nalossone | HMDB | Abello brand OF naloxone hydrochloride | HMDB | Abello, naloxone | HMDB | Boots brand OF naloxone hydrochloride | HMDB | Bristol-myers squibb brand OF naloxone hydrochloride | HMDB | Curamed brand OF naloxone hydrochloride | HMDB | endo Brand OF naloxone hydrochloride | HMDB | Narcanti | HMDB | Ratiopharm brand OF naloxone hydrochloride | HMDB | Dihydride, naloxone hydrochloride | HMDB | Naloxon ratiopharm | HMDB | Naloxone hydrochloride | HMDB | Naloxone hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-isomer | HMDB | SERB brand OF naloxone hydrochloride | HMDB | Bristol myers squibb brand OF naloxone hydrochloride | HMDB | Curamed, naloxon | HMDB | Lamepro brand OF naloxone hydrochloride | HMDB | MRZ 2593BR | HMDB | Nalone | HMDB | Naloxon-ratiopharm | HMDB | Hydrobromide, naloxone | HMDB | Hydrochloride dihydride, naloxone | HMDB | Hydrochloride, naloxone | HMDB | MRZ 2593 BR | HMDB | MRZ 2593-BR | HMDB | Naloxon curamed | HMDB | Naloxone abello | HMDB | Naloxone hydrochloride dihydride | HMDB | Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-isomer | HMDB | Naloxonratiopharm | HMDB | Naloxone hydrobromide | HMDB | Narcan | HMDB | United drug brand OF naloxone hydrochloride | HMDB |
|
---|
Chemical Formula | C19H21NO4 |
---|
Average Molecular Weight | 327.3743 |
---|
Monoisotopic Molecular Weight | 327.147058165 |
---|
IUPAC Name | (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-14-one |
---|
Traditional Name | naloxone |
---|
CAS Registry Number | 465-65-6 |
---|
SMILES | [H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(CC=C)[C@]([H])(C4)[C@]1(O)CCC2=O |
---|
InChI Identifier | InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1 |
---|
InChI Key | UZHSEJADLWPNLE-GRGSLBFTSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenanthrenes and derivatives. These are polycyclic compounds containing a phenanthrene moiety, which is a tricyclic aromatic compound with three non-linearly fused benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenanthrenes and derivatives |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenanthrenes and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenanthrene
- Isoquinolone
- Tetralin
- Coumaran
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Aralkylamine
- Piperidine
- Cyclic alcohol
- Tertiary alcohol
- 1,2-aminoalcohol
- Ketone
- Tertiary aliphatic amine
- Tertiary amine
- Ether
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organic nitrogen compound
- Organopnictogen compound
- Carbonyl group
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 200 - 205 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 5.64 g/L | Not Available | LogP | 0.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 171.8 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Naloxone,1TMS,isomer #1 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C)=C4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5 | 2724.2 | Semi standard non polar | 33892256 | Naloxone,1TMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O)=C4O[C@H]2C(=O)CC[C@@]3(O[Si](C)(C)C)[C@H]1C5 | 2669.8 | Semi standard non polar | 33892256 | Naloxone,1TMS,isomer #3 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C)CC[C@@]2(O)[C@H]1CC1=CC=C(O)C(=C13)O4 | 2717.1 | Semi standard non polar | 33892256 | Naloxone,1TMS,isomer #4 | C=CCN1CC[C@]23C4=C5C=CC(O)=C4O[C@H]2C(O[Si](C)(C)C)=CC[C@@]3(O)[C@H]1C5 | 2677.6 | Semi standard non polar | 33892256 | Naloxone,2TMS,isomer #1 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C)=C4O[C@H]2C(=O)CC[C@@]3(O[Si](C)(C)C)[C@H]1C5 | 2693.0 | Semi standard non polar | 33892256 | Naloxone,2TMS,isomer #2 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C)CC[C@@]2(O)[C@H]1CC1=CC=C(O[Si](C)(C)C)C(=C13)O4 | 2724.8 | Semi standard non polar | 33892256 | Naloxone,2TMS,isomer #3 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C)=CC[C@@]3(O)[C@H]1C5 | 2693.9 | Semi standard non polar | 33892256 | Naloxone,2TMS,isomer #4 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C)CC[C@@]2(O[Si](C)(C)C)[C@H]1CC1=CC=C(O)C(=C13)O4 | 2664.5 | Semi standard non polar | 33892256 | Naloxone,2TMS,isomer #5 | C=CCN1CC[C@]23C4=C5C=CC(O)=C4O[C@H]2C(O[Si](C)(C)C)=CC[C@@]3(O[Si](C)(C)C)[C@H]1C5 | 2651.3 | Semi standard non polar | 33892256 | Naloxone,3TMS,isomer #1 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C)CC[C@@]2(O[Si](C)(C)C)[C@H]1CC1=CC=C(O[Si](C)(C)C)C(=C13)O4 | 2715.2 | Semi standard non polar | 33892256 | Naloxone,3TMS,isomer #1 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C)CC[C@@]2(O[Si](C)(C)C)[C@H]1CC1=CC=C(O[Si](C)(C)C)C(=C13)O4 | 2841.0 | Standard non polar | 33892256 | Naloxone,3TMS,isomer #1 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C)CC[C@@]2(O[Si](C)(C)C)[C@H]1CC1=CC=C(O[Si](C)(C)C)C(=C13)O4 | 3293.2 | Standard polar | 33892256 | Naloxone,3TMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C)=CC[C@@]3(O[Si](C)(C)C)[C@H]1C5 | 2726.8 | Semi standard non polar | 33892256 | Naloxone,3TMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C)=CC[C@@]3(O[Si](C)(C)C)[C@H]1C5 | 2793.8 | Standard non polar | 33892256 | Naloxone,3TMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C)=CC[C@@]3(O[Si](C)(C)C)[C@H]1C5 | 3265.3 | Standard polar | 33892256 | Naloxone,1TBDMS,isomer #1 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C(C)(C)C)=C4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5 | 2979.7 | Semi standard non polar | 33892256 | Naloxone,1TBDMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O)=C4O[C@H]2C(=O)CC[C@@]3(O[Si](C)(C)C(C)(C)C)[C@H]1C5 | 2910.7 | Semi standard non polar | 33892256 | Naloxone,1TBDMS,isomer #3 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C(C)(C)C)CC[C@@]2(O)[C@H]1CC1=CC=C(O)C(=C13)O4 | 2960.2 | Semi standard non polar | 33892256 | Naloxone,1TBDMS,isomer #4 | C=CCN1CC[C@]23C4=C5C=CC(O)=C4O[C@H]2C(O[Si](C)(C)C(C)(C)C)=CC[C@@]3(O)[C@H]1C5 | 2919.9 | Semi standard non polar | 33892256 | Naloxone,2TBDMS,isomer #1 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C(C)(C)C)=C4O[C@H]2C(=O)CC[C@@]3(O[Si](C)(C)C(C)(C)C)[C@H]1C5 | 3146.5 | Semi standard non polar | 33892256 | Naloxone,2TBDMS,isomer #2 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C(C)(C)C)CC[C@@]2(O)[C@H]1CC1=CC=C(O[Si](C)(C)C(C)(C)C)C(=C13)O4 | 3191.7 | Semi standard non polar | 33892256 | Naloxone,2TBDMS,isomer #3 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C(C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C(C)(C)C)=CC[C@@]3(O)[C@H]1C5 | 3153.0 | Semi standard non polar | 33892256 | Naloxone,2TBDMS,isomer #4 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C(C)(C)C)CC[C@@]2(O[Si](C)(C)C(C)(C)C)[C@H]1CC1=CC=C(O)C(=C13)O4 | 3114.6 | Semi standard non polar | 33892256 | Naloxone,2TBDMS,isomer #5 | C=CCN1CC[C@]23C4=C5C=CC(O)=C4O[C@H]2C(O[Si](C)(C)C(C)(C)C)=CC[C@@]3(O[Si](C)(C)C(C)(C)C)[C@H]1C5 | 3090.0 | Semi standard non polar | 33892256 | Naloxone,3TBDMS,isomer #1 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C(C)(C)C)CC[C@@]2(O[Si](C)(C)C(C)(C)C)[C@H]1CC1=CC=C(O[Si](C)(C)C(C)(C)C)C(=C13)O4 | 3348.2 | Semi standard non polar | 33892256 | Naloxone,3TBDMS,isomer #1 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C(C)(C)C)CC[C@@]2(O[Si](C)(C)C(C)(C)C)[C@H]1CC1=CC=C(O[Si](C)(C)C(C)(C)C)C(=C13)O4 | 3464.2 | Standard non polar | 33892256 | Naloxone,3TBDMS,isomer #1 | C=CCN1CC[C@]23C4=C(O[Si](C)(C)C(C)(C)C)CC[C@@]2(O[Si](C)(C)C(C)(C)C)[C@H]1CC1=CC=C(O[Si](C)(C)C(C)(C)C)C(=C13)O4 | 3528.8 | Standard polar | 33892256 | Naloxone,3TBDMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C(C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C(C)(C)C)=CC[C@@]3(O[Si](C)(C)C(C)(C)C)[C@H]1C5 | 3354.4 | Semi standard non polar | 33892256 | Naloxone,3TBDMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C(C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C(C)(C)C)=CC[C@@]3(O[Si](C)(C)C(C)(C)C)[C@H]1C5 | 3339.5 | Standard non polar | 33892256 | Naloxone,3TBDMS,isomer #2 | C=CCN1CC[C@]23C4=C5C=CC(O[Si](C)(C)C(C)(C)C)=C4O[C@H]2C(O[Si](C)(C)C(C)(C)C)=CC[C@@]3(O[Si](C)(C)C(C)(C)C)[C@H]1C5 | 3474.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Naloxone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a6r-9042000000-3da4b2172456d62748f0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Naloxone GC-MS (2 TMS) - 70eV, Positive | splash10-004i-9703600000-474943cf0224b80b9bab | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Naloxone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Naloxone LC-ESI-qTof , Positive-QTOF | splash10-00di-0900000000-6b7de93b51a79132630f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Naloxone , positive-QTOF | splash10-004i-0139000000-e70921e0765c3389ce85 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Naloxone 40V, Positive-QTOF | splash10-03di-0790000000-385321bfef7553f8994a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Naloxone 10V, Positive-QTOF | splash10-004i-0009000000-2b2b5b609cf6e1a1d0a7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Naloxone 20V, Positive-QTOF | splash10-03di-0019000000-fdc81a17ea0adfa1d6b1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 10V, Positive-QTOF | splash10-03fr-0009000000-1e89424c27afc0579ffc | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 20V, Positive-QTOF | splash10-03dl-5079000000-7ad11d1224dead9d51b5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 40V, Positive-QTOF | splash10-0006-9030000000-102851f487961aeb63cb | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 10V, Negative-QTOF | splash10-004i-0009000000-8c2763e72d5fce389611 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 20V, Negative-QTOF | splash10-056r-0049000000-d9a6f9d54d49fda8a151 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 40V, Negative-QTOF | splash10-00ku-2090000000-fbfe8d648c7bfc3bbe9f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 10V, Positive-QTOF | splash10-004i-0009000000-354160c39518aa1987e3 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 20V, Positive-QTOF | splash10-03fr-0019000000-c4826be6e2657469ccea | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 40V, Positive-QTOF | splash10-00b9-0096000000-16546df9ae1b2c3cee96 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 10V, Negative-QTOF | splash10-004i-0009000000-82e8b7e0c70cdc0f9fe6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 20V, Negative-QTOF | splash10-004i-0009000000-ad63c6111240451f0f01 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Naloxone 40V, Negative-QTOF | splash10-00b9-0049000000-d10f137bf09021c8d430 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum |
|
---|